6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Mental Health Outcomes in Substance Abuse Recovery
Substance abuse recovery is deeply tied to improvements in mental health, as addressing addiction often involves resolving psychological challenges. Recovery programs commonly incorporate therapies like cognitive-behavioral therapy (CBT) and trauma-informed care to address underlying mental health conditions, including anxiety, depression, or PTSD. As individuals progress, they often experience enhanced emotional stability, improved self-worth, and better interpersonal relationships. Stress management techniques, mindfulness practices, and peer support groups contribute to long-term mental health benefits. These positive outcomes not only reinforce sobriety but also improve overall quality of life, helping individuals rebuild a sense of purpose and connection.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States